- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/06 - Antiasthmatics
Patent holdings for IPC class A61P 11/06
Total number of patents in this class: 3878
10-year publication summary
|
120
|
196
|
261
|
255
|
275
|
251
|
224
|
216
|
216
|
151
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2826 |
86 |
| F. Hoffmann-La Roche AG | 7792 |
78 |
| Chiesi Farmaceutici S.p.A. | 953 |
58 |
| Genentech, Inc. | 4147 |
45 |
| Daiichi Sankyo Company, Limited | 1894 |
45 |
| Boehringer Ingelheim International GmbH | 4480 |
42 |
| Regeneron Pharmaceuticals, Inc. | 4822 |
36 |
| Bristol-myers Squibb Company | 4761 |
30 |
| Takeda Pharmaceutical Company Limited | 2700 |
28 |
| Hoffmann-La Roche Inc. | 3849 |
27 |
| The Regents of the University of California | 20924 |
27 |
| Theravance Biopharma R&D IP, LLC | 358 |
26 |
| Glaxo Group Limited | 4353 |
25 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
24 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3357 |
24 |
| Novartis AG | 10172 |
23 |
| Almirall, S.A. | 486 |
19 |
| Astellas Pharma Inc. | 1039 |
19 |
| Nippon Shinyaku Co., Ltd. | 325 |
19 |
| Sanofi Biotechnology | 341 |
19 |
| Other owners | 3178 |